Cargando…

Decompensated heart failure

Heart failure is a disease with high incidence and prevalence in the population. The costs with hospitalization for decompensated heart failure reach approximately 60% of the total cost with heart failure treatment, and mortality during hospitalization varies according to the studied population, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangini, Sandrigo, Pires, Philippe Vieira, Braga, Fabiana Goulart Marcondes, Bacal, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878602/
https://www.ncbi.nlm.nih.gov/pubmed/24136770
http://dx.doi.org/10.1590/S1679-45082013000300022
_version_ 1782433583566159872
author Mangini, Sandrigo
Pires, Philippe Vieira
Braga, Fabiana Goulart Marcondes
Bacal, Fernando
author_facet Mangini, Sandrigo
Pires, Philippe Vieira
Braga, Fabiana Goulart Marcondes
Bacal, Fernando
author_sort Mangini, Sandrigo
collection PubMed
description Heart failure is a disease with high incidence and prevalence in the population. The costs with hospitalization for decompensated heart failure reach approximately 60% of the total cost with heart failure treatment, and mortality during hospitalization varies according to the studied population, and could achieve values of 10%. In patients with decompensated heart failure, history and physical examination are of great value for the diagnosis of the syndrome, and also can help the physician to identify the beginning of symptoms, and give information about etiology, causes and prognosis of the disease. The initial objective of decompensated heart failure treatment is the hemodynamic and symptomatic improvement preservation and/or improvement of renal function, prevention of myocardial damage, modulation of the neurohormonal and/or inflammatory activation and control of comorbidities that can cause or contribute to progression of the syndrome. According to the clinical-hemodynamic profile, it is possible to establish a rational for the treatment of decompensated heart failure, individualizing the proceedings to be held, leading to reduction in the period of hospitalization and consequently reducing overall mortality.
format Online
Article
Text
id pubmed-4878602
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Instituto Israelita de Ensino e Pesquisa Albert Einstein
record_format MEDLINE/PubMed
spelling pubmed-48786022016-08-10 Decompensated heart failure Mangini, Sandrigo Pires, Philippe Vieira Braga, Fabiana Goulart Marcondes Bacal, Fernando Einstein (Sao Paulo) Review Heart failure is a disease with high incidence and prevalence in the population. The costs with hospitalization for decompensated heart failure reach approximately 60% of the total cost with heart failure treatment, and mortality during hospitalization varies according to the studied population, and could achieve values of 10%. In patients with decompensated heart failure, history and physical examination are of great value for the diagnosis of the syndrome, and also can help the physician to identify the beginning of symptoms, and give information about etiology, causes and prognosis of the disease. The initial objective of decompensated heart failure treatment is the hemodynamic and symptomatic improvement preservation and/or improvement of renal function, prevention of myocardial damage, modulation of the neurohormonal and/or inflammatory activation and control of comorbidities that can cause or contribute to progression of the syndrome. According to the clinical-hemodynamic profile, it is possible to establish a rational for the treatment of decompensated heart failure, individualizing the proceedings to be held, leading to reduction in the period of hospitalization and consequently reducing overall mortality. Instituto Israelita de Ensino e Pesquisa Albert Einstein 2013 /pmc/articles/PMC4878602/ /pubmed/24136770 http://dx.doi.org/10.1590/S1679-45082013000300022 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Mangini, Sandrigo
Pires, Philippe Vieira
Braga, Fabiana Goulart Marcondes
Bacal, Fernando
Decompensated heart failure
title Decompensated heart failure
title_full Decompensated heart failure
title_fullStr Decompensated heart failure
title_full_unstemmed Decompensated heart failure
title_short Decompensated heart failure
title_sort decompensated heart failure
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878602/
https://www.ncbi.nlm.nih.gov/pubmed/24136770
http://dx.doi.org/10.1590/S1679-45082013000300022
work_keys_str_mv AT manginisandrigo decompensatedheartfailure
AT piresphilippevieira decompensatedheartfailure
AT bragafabianagoulartmarcondes decompensatedheartfailure
AT bacalfernando decompensatedheartfailure